Contineum Therapeutics, Inc. (CTNM) Misses Q1 EPS by 20c

Contineum Therapeutics, Inc. (NASDAQ: CTNM) reported Q1 EPS of ($0.62), $0.20 worse than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Contineum Therapeutics, Inc. (CTNM) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15